Met Life Investment Management, LLC Outlook Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $14.7 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Apr 29, 2024
BUY
$1.02 - $1.89 $85,103 - $157,692
83,435 New
83,435 $145,000
Q1 2023

May 09, 2024
BUY
$1.0 - $1.35 $83,435 - $112,637
83,435 New
83,435 $90.9 Million
Q1 2023

May 15, 2023
BUY
$1.0 - $1.35 $83,435 - $112,637
83,435 New
83,435 $90,000

Others Institutions Holding OTLK

# of Institutions
7
Shares Held
67.1K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.66B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email